Mml Investors Services »

Biomarin Pharmaceutical shares owned by Mml Investors Services

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Mml Investors Services from 13F filings

Historical chart of Mml Investors Services investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Mml Investors Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Mml Investors Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $47k 49k 0.96

More positions owned by Mml Investors Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Mml Investors Services

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Lazard Asset Management
BlackRock
Man Group
Capstone Investment Advisors
MacKay Shields
Opti Capital Management
Millennium Management
Verition Fund Management
Oaktree Capital Management
Victory Capital Management
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Jpmorgan Chase & Co

View all funds holding Biomarin Pharmaceutical